Professional Summary
Professional Overview
Ivan Efremov is an accomplished chemist with over 20 years of experience in the pharmaceutical industry. He is currently the VP, Head of Chemistry at Nereid Therapeutics, where he leads a team of talented scientists in the development of novel therapeutic compounds.
Experience Summary
Current Role
As the VP, Head of Chemistry at Nereid Therapeutics, Ivan is responsible for overseeing all chemistry-related activities, including medicinal chemistry, process chemistry, and analytical chemistry. In this role, he has successfully guided the advancement of several drug candidates through the development pipeline, with a focus on delivering safe and effective therapies to patients.
Career Progression
Prior to joining Nereid Therapeutics, Ivan held several leadership positions at Fulcrum Therapeutics, where he served as the VP, Head of Medicinal Chemistry and led a team of chemists in the discovery and optimization of small-molecule modulators for rare genetic diseases. Before that, he spent over a decade at Pfizer, where he progressed through roles of increasing responsibility, ultimately serving as a Senior Principal Scientist and contributing to the development of multiple clinical-stage compounds.
Academic Background
Ivan holds a Ph.D. in Organic Chemistry from the University of California, Berkeley, where his research focused on the synthesis and characterization of novel heterocyclic compounds. He also completed a postdoctoral fellowship at the Massachusetts Institute of Technology, further enhancing his expertise in synthetic methodology and medicinal chemistry.
Areas of Expertise
- Medicinal chemistry
- Small-molecule drug discovery and optimization
- Organic synthesis
- Analytical chemistry
- Project management
- Team leadership and mentorship
Professional Impact
Throughout his career, Ivan has made significant contributions to the pharmaceutical industry, including the successful development of several clinical-stage drug candidates. He is known for his strategic thinking, innovative problem-solving, and ability to effectively collaborate with cross-functional teams to drive drug discovery and development initiatives.
Conclusion
With his extensive experience, deep scientific expertise, and proven track record of success, Ivan Efremov is a valuable asset to Nereid Therapeutics, where he continues to push the boundaries of chemistry-driven drug discovery and development.
